Women with PMOS should get subsidised weight-loss drugs, Australian advocates say
Global - Oceania
Archived
•
October 9, 2026
•
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight-loss medications, advocates say.The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition. Continue reading...
Source: Guardian World | https://www.theguardian.com/world/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



